(Q37349668)

19 August 2017

1 reference

title

RNA editing as a therapeutic target for CNS disorders (English)

1 reference

19 August 2017

Michael V Morabito

1

1 reference

19 August 2017

Ronald B Emeson

series ordinal

2

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 January 2009

1 reference

19 August 2017

Neuropsychopharmacology

1 reference

19 August 2017

34

1 reference

19 August 2017

1

1 reference

19 August 2017

246

1 reference

https://scigraph.springernature.com/pub.10.1038/npp.2008.159

19 August 2017

0 references

cites work

Altered editing of serotonin 2C receptor pre-mRNA in the prefrontal cortex of depressed suicide victims

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.159

Deficient RNA editing of GluR2 and neuronal death in amyotropic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.159

RNA editing of the human serotonin 5-HT2C receptor. alterations in suicide and implications for serotonergic pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.159

The role of RNA editing of kainate receptors in synaptic plasticity and seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.159

RNA editing (R/G site) and flip-flop splicing of the AMPA receptor subunit GluR2 in nervous tissue of epilepsy patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.159

Mouse models to elucidate the functional roles of adenosine-to-inosine editing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2008.159

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NPP.2008.159

1 reference

Dimensions Publication ID

19 August 2017

0 references

1 reference